Avidity Biosciences
RNA
#2567
Rank
C$7.78 B
Marketcap
$65.22
Share price
-0.83%
Change (1 day)
724.87%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : C$1.81 Billion

According to Avidity Biosciences's latest financial reports the company has C$1.81 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.78 B-4.72%
2022-12-31C$0.82 B60.34%
2021-12-31C$0.51 B23.53%
2020-12-31C$0.41 B238.72%
2019-12-31C$0.12 B2834.63%
2018-12-31C$4.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.41 B-21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.06 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.67 B-7.75%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.61 B-65.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.42 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.88 B 666.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.99 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK